Join to View Full Profile
200 1st St SwRochester, MN 55905
Dr. Ho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2014 - 2017
David Geffen School of Medicine at UCLAClass of 2013
Certifications & Licensure
MN State Medical License 2015 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A First-in-Human, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BJ-005 in Patients With Advanced Solid Tumor or Lymphoma Start of enrollment: 2021 Oct 20
Roles: Contact
Publications & Presentations
PubMed
- A Phase II Multi-Center Trial of Trabectedin in Combination with Olaparib in Patients with Advanced Unresectable or Metastatic Sarcoma.Brittany L Siontis, John D Rice, Scott M Schuetze, Douglas Rottmann, Christina V Angeles
Clinical Cancer Research. 2025-05-13 - 79-Year-Old Man Presenting With Abdominal Distention.Jack Korleski, Joshua Daum, Thanh Ho
Mayo Clinic Proceedings. 2025-03-01 - Outcomes of Scapular Osteosarcoma.Leilani Garayua-Cruz, Samuel E Broida, Steven I Robinson, Scott H Okuno, Thanh P Ho
Anticancer Research. 2025-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
